CTSO CytoSorbents Corporation

NASDAQ
$4.80

CytoSorbents Corporation (CTSO) is confirmed to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.90 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -36.8% since its last earnings release on August 6, 2026.

CytoSorbents Missed Consensus Estimates
Thursday, August 6, 2026 · 4:25 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:25 PM ET
Earnings Whisper
-
vs ($0.90)
Rev est $9.92M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CytoSorbents Corporation

Cytosorbents Corp is a development stage company. The Company, through its subsidiary, is engaged in the research, development and commercialization of medical devices.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.